Case Reports in Oncology
Scope & Guideline
Sharing Unique Clinical Experiences
Introduction
Aims and Scopes
- Case Reports of Rare Cancers:
The journal emphasizes the importance of documenting unusual cancer presentations and rare malignancies, providing valuable insights into their clinical management and treatment. - Innovative Treatment Approaches:
It highlights case reports that explore new treatment modalities, including targeted therapies, immunotherapies, and combination regimens, showcasing their efficacy and safety in various cancer types. - Multidisciplinary Perspectives:
The journal encourages submissions that reflect a multidisciplinary approach to cancer care, integrating input from medical oncologists, surgeons, radiologists, and pathologists. - Patient Outcomes and Follow-ups:
The focus is on detailed follow-up of patients post-treatment, providing data on long-term outcomes, recurrence rates, and survival, which are crucial for improving clinical practices. - Emerging Genetic and Molecular Insights:
The journal includes case reports that delve into the genetic and molecular underpinnings of cancers, enhancing the understanding of tumor biology and potential targeted therapies.
Trending and Emerging
- Immunotherapy and Targeted Therapies:
There is a significant rise in case reports documenting the use of immunotherapy and targeted therapies, showcasing their effectiveness and expanding the therapeutic options available to patients. - Personalized Medicine:
Emerging themes include case reports that focus on personalized treatment approaches based on genetic testing and molecular profiling, highlighting the shift towards tailored cancer therapy. - Combination Therapies:
The journal increasingly features reports on novel combination therapies, illustrating the trend towards integrating various treatment modalities for enhanced efficacy. - Long-Term Follow-Up Studies:
A growing number of submissions emphasize long-term follow-up and outcomes, reflecting the importance of understanding the durability of treatment responses and late effects. - Real-World Evidence and Patient Experiences:
There is a trend towards incorporating real-world evidence and patient-reported outcomes in case reports, providing insights into the practical implications of treatments in everyday clinical settings.
Declining or Waning
- Traditional Chemotherapy Case Reports:
There has been a noticeable decrease in case reports focusing solely on traditional chemotherapy treatments, as the oncology field increasingly emphasizes targeted therapies and immunotherapy. - Standard Surgical Techniques:
Case reports detailing standard surgical approaches without new insights or innovations are becoming less common, as the focus shifts towards minimally invasive procedures and novel surgical techniques. - Palliative Care Cases:
The frequency of case reports centered on palliative care alone has diminished, possibly due to a growing emphasis on curative and transformative therapies in oncology. - Common Cancer Types:
Reports on well-known malignancies, such as breast and lung cancer, without unique angles or significant clinical insights are less frequently submitted, indicating a preference for more complex or rare cases. - Historical Treatment Comparisons:
There is a decline in the publication of case reports comparing historical treatment regimens, as the field rapidly evolves and focuses on contemporary practices.
Similar Journals
BMJ Case Reports
Uncovering Rare Medical Narratives for Enhanced CareBMJ Case Reports is a vital resource within the field of medicine, published by the esteemed BMJ PUBLISHING GROUP. With an E-ISSN of 1757-790X and a focus on disseminating high-quality case reports, this journal serves as a platform for healthcare professionals, researchers, and students to share unique clinical experiences and uncommon presentations of medical conditions. Since its inception in 2008 and continuing through 2024, it has gained recognition for contributing to the advancement of medical knowledge, currently ranking at Q4 in the Medicine (miscellaneous) category and positioned in the 54th percentile in General Medicine according to Scopus rankings. Although it is a subscription-based journal, its impact on clinical practice and education is significant, enabling practitioners to learn from diverse case studies and improving patient care outcomes. As it aims to enhance the understanding of rare and significant medical cases, BMJ Case Reports remains an essential publication for those at the forefront of medical innovation.
Case Reports in Oncological Medicine
Elevating patient care with detailed case studies.Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.
International Cancer Conference Journal
Innovating Oncology: Insights for a Healthier TomorrowInternational Cancer Conference Journal, published by Springer International Publishing AG, serves as a pivotal platform for the dissemination of cutting-edge research in the field of oncology. With a commitment to advancing the understanding, prevention, and treatment of cancer, this journal offers a forum for the presentation of innovative studies, clinical trials, and comprehensive reviews that cater to the needs of researchers, healthcare professionals, and students alike. Although currently not open access, the journal is dedicated to fostering collaboration and knowledge sharing within the cancer research community. The ISSN for this journal is 2192-3183, ensuring its listing within prominent academic databases for enhanced visibility. Hailing from Switzerland, the journal aspires to impact the global dialogue on cancer through rigorous peer-reviewed articles and special conference proceedings, making it an essential resource for those dedicated to the fight against cancer.
Medical Mycology Case Reports
Empowering practitioners with essential mycological knowledge.Medical Mycology Case Reports, published by Elsevier, is a pivotal journal dedicated to advancing the field of mycology through the presentation of case reports that highlight clinical findings, diagnostic challenges, and treatment outcomes associated with fungal infections. With its ISSN 2211-7539 and E-ISSN 2211-7539, this open-access journal has been serving the global community since 2012, allowing unrestricted access to its valuable insights. Situated in the Netherlands, specifically at RADARWEG 29, AMSTERDAM, this journal has gained recognition in areas such as Infectious Diseases (ranked Q3) and Microbiology (ranked Q4) as of 2023. Its commitment to disseminating high-quality research is reflected in its Scopus rankings, which place it at the 51st percentile in Medicine and the 32nd percentile in Immunology and Microbiology. By bridging the gap between clinical cases and academic research, Medical Mycology Case Reports plays a crucial role in enriching the knowledge base of practitioners and researchers alike, ultimately contributing to improved patient management and public health.
Case Reports in Orthopedics
Empowering the orthopedic community with shared experiences and discoveries.Case Reports in Orthopedics is a pivotal journal dedicated to the field of orthopedics, published by HINDAWI LTD. Since its inception as an open-access platform in 2011, it has steadily established itself as a valuable resource for researchers, practitioners, and students seeking insights into unique clinical cases and innovative treatment methodologies. The journal aims to promote the sharing of knowledge through detailed case reports that foster discussion and inspire further research within the orthopedic community. Although it currently does not have a designated impact factor, its commitment to advancing the field is evident in its comprehensive articles accessible to a global audience. The journal’s open access policy ensures that critical findings are disseminated widely, facilitating ongoing education and collaboration among orthopedic specialists. By bridging the gap between clinical practice and research, Case Reports in Orthopedics continues to play an essential role in enhancing patient care and advancing orthopedic science.
Case Reports in Gastrointestinal Medicine
Transforming gastrointestinal medicine through shared experiences.Case Reports in Gastrointestinal Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of significant findings in the field of gastrointestinal medicine. Established in 2011, this journal champions the accessibility of scholarly work, allowing researchers, professionals, and students to explore vital case studies that enhance clinical understanding and patient care across various gastrointestinal conditions. With an emphasis on innovative practices and advances in treatment, the journal serves as an invaluable resource for those committed to furthering their knowledge and improving outcomes in gastrointestinal health. By promoting the robust sharing of case reports and clinical insights, Case Reports in Gastrointestinal Medicine not only contributes to the academic community but also supports practitioners in their quest for evidence-based practice.
Blood and Lymphatic Cancer-Targets and Therapy
Empowering Research in Blood and Lymphatic CancerBlood and Lymphatic Cancer-Targets and Therapy, published by DOVE MEDICAL PRESS LTD, is a vital open-access journal that has been disseminating crucial research and findings in the field of hematology and oncology since 2011. With its ISSN 1179-9889, this journal focuses on the latest therapeutic targets and innovative treatment strategies for blood and lymphatic cancers, contributing significantly to the advancement of knowledge and practice in this specialized area. Designed for researchers, healthcare professionals, and students alike, Blood and Lymphatic Cancer-Targets and Therapy aims to foster a deeper understanding of cancer biology and promote collaborative efforts leading to novel therapeutic interventions. The open-access model ensures that research findings are readily accessible to a global audience, underscoring the journal's commitment to enhancing patient care and fostering educational growth in the cancer domain.
World Journal of Clinical Oncology
Transforming Patient Care through Groundbreaking ResearchWorld Journal of Clinical Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a vital resource in the realm of oncology, providing a dedicated platform for the dissemination of cutting-edge research and clinical advancements. With an ISSN of 2218-4333, this journal facilitates a comprehensive exploration of modern oncology challenges and breakthroughs, targeting researchers, healthcare professionals, and students alike. Although it operates under the traditional subscription model, the impactful nature of its content is reflected in its notable ranking of 60 out of 334 in the category of Medicine _ Oncology, placing it in the 82nd percentile among peer publications. Covering significant topics in clinical oncology from 2014 to 2018, the journal has been instrumental in addressing evolving oncology practices and patient care innovations. By publishing high-quality studies, it remains an essential tool for advancing knowledge and fostering collaboration within the global oncology community.
Thoracic and Cardiovascular Surgeon Reports
Empowering surgeons with cutting-edge research and insights.Thoracic and Cardiovascular Surgeon Reports is a pivotal academic journal dedicated to the dissemination of innovative research and clinical practices in the fields of thoracic and cardiovascular surgery. Published by GEORG THIEME VERLAG KG, this journal has been an open-access publication since 2013, fostering a broader reach and enhancing visibility for authors and researchers globally. With its commitment to high-quality peer-reviewed articles, Thoracic and Cardiovascular Surgeon Reports serves as an essential platform for surgeons, clinicians, and scholars to share findings that advance medical knowledge, improve patient outcomes, and refine surgical techniques. The journal aims to bridge the gap between research and practical application, catering to an audience keen on staying updated with the latest in thoracic and cardiovascular interventions, making it a valuable resource in an ever-evolving medical landscape.
Journal of Kidney Cancer and VHL
Promoting innovation in kidney cancer therapies.The Journal of Kidney Cancer and VHL stands as a leading platform for disseminating cutting-edge research in the field of renal oncology, particularly focused on kidney cancer and Von Hippel-Lindau (VHL) disease. Published by CODON PUBLICATIONS since its inception, this Open Access journal, with ready accessibility since 2014, aims to foster knowledge exchange and collaboration among researchers, clinicians, and healthcare professionals dedicated to improving outcomes for patients with kidney cancer. With an ISSN of 2203-5826, this journal serves as a vital resource in the academic community, encouraging submissions that span various topics, including epidemiology, treatment modalities, and innovative therapeutic strategies. By providing unrestricted access to its content, the Journal of Kidney Cancer and VHL promotes inclusive participation in the global dialogue surrounding these critical health challenges, ensuring that the latest findings reach all corners of the scientific community.